Prediction of drug–drug interactions between roflumilast and CYP3A4/1A2 perpetrators using a physiologically-based pharmacokinetic (PBPK) approach
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Prediction of drug–drug interactions between roflumilast and CYP3A4/1A2 perpetrators using a physiologically-based pharmacokinetic (PBPK) approach ; volume:25 ; number:1 ; day:2 ; month:1 ; year:2024 ; pages:1-13 ; date:12.2024
BMC pharmacology & toxicology ; 25, Heft 1 (2.1.2024), 1-13, 12.2024
- Creator
-
Jia, Guangwei
Ren, Congcong
Wang, Hongyan
Fan, Caixia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40360-023-00726-2
- URN
-
urn:nbn:de:101:1-2024031508405580246564
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jia, Guangwei
- Ren, Congcong
- Wang, Hongyan
- Fan, Caixia
- SpringerLink (Online service)
Other Objects (12)
A Cognitive Method for Musicology Based Melody Transcription
A New Pathology in the Simulation of Chaotic Dynamical Systems on Digital Computers
Drug-drug interaction perpetrators of oxycodone in patients with cancer: frequency and clinical relevance
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib
Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling
Msps governs acentrosomal microtubule assembly and reactivation of quiescent neural stem cells
Characterization of NiCas12b for In Vivo Genome Editing
A Review of Daclatasvir Drug–Drug Interactions
A Cognitive Method for Musicology Based Melody Transcription
A New Pathology in the Simulation of Chaotic Dynamical Systems on Digital Computers
Drug-drug interaction perpetrators of oxycodone in patients with cancer: frequency and clinical relevance
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib
Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling
Msps governs acentrosomal microtubule assembly and reactivation of quiescent neural stem cells
Characterization of NiCas12b for In Vivo Genome Editing
A Review of Daclatasvir Drug–Drug Interactions
A Cognitive Method for Musicology Based Melody Transcription
A New Pathology in the Simulation of Chaotic Dynamical Systems on Digital Computers
Drug-drug interaction perpetrators of oxycodone in patients with cancer: frequency and clinical relevance
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib
Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling
Msps governs acentrosomal microtubule assembly and reactivation of quiescent neural stem cells
Characterization of NiCas12b for In Vivo Genome Editing